Literature DB >> 24328427

Differential upregulation of human 2'5'OAS genes on systemic sclerosis: Detection of increased basal levels of OASL and OAS2 genes through a qPCR based assay.

Gabriel Magno de Freitas Almeida1, Danilo Bretas de Oliveira, Lucas Moreira Botelho, Ludmila Karen dos Santos Silva, Antônio Carlos Martins Guedes, Flávia Patrícia Sena Teixeira Santos, Cláudio Antônio Bonjardim, Paulo César Peregrino Ferreira, Erna Geessien Kroon.   

Abstract

2'5'OAS are template-independent RNA polymerases with antiviral activity and important to homeostasis maintenance. Here we have developed quantitative PCR (qPCR) reactions for the detection of each individual 2'5'OAS human gene and used them to evaluate these gene levels in systemic sclerosis patients cells. The method was efficient for quantification of 2'5'OAS genes on human cells after interferon (IFN) treatment, and revealed that primary cells from patients with systemic sclerosis have increased basal levels of OASL and OAS2 genes. When treated, patients cells are able to induce all four 2'5'OAS genes. Our hypothesis is that abnormally circulating type I IFNs on the disease could be establishing a desensitized state on patients cells, making them refractory to subsequent IFN doses, and that OASL and OAS2 genes upregulation may be due to an IFN-independent stimulus. Further characterizing the biological activities of these genes, their induction pathways and their regulatory functions can lead to better understanding of systemic sclerosis molecular mechanisms and of their biological activities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24328427     DOI: 10.3109/08916934.2013.866102

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

Review 1.  Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases.

Authors:  Un Yung Choi; Ji-Seon Kang; Yune Sahng Hwang; Young-Joon Kim
Journal:  Exp Mol Med       Date:  2015-03-06       Impact factor: 8.718

2.  Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice.

Authors:  Merri-Grace Allred; Michael S Chimenti; Ashley E Ciecko; Yi-Guang Chen; Scott M Lieberman
Journal:  Int J Mol Sci       Date:  2021-04-05       Impact factor: 5.923

3.  Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling.

Authors:  Yaqian Shi; Rong Xiao; Zhuotong Zeng; Yaoyao Wang; Yangfan Xiao; Jie Zheng; Ruizhen Liu; Xinglan He; Jiangfan Yu; Bingsi Tang; Xiangning Qiu; Rui Tang
Journal:  Arthritis Res Ther       Date:  2022-02-19       Impact factor: 5.156

4.  Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE.

Authors:  Yaneli Juárez-Vicuña; Julia Pérez-Ramos; Laura Adalid-Peralta; Fausto Sánchez; Laura Aline Martínez-Martínez; María Del Carmen Ortiz-Segura; Edgar Pichardo-Ontiveros; Adrián Hernández-Díazcouder; Luis M Amezcua-Guerra; Julian Ramírez-Bello; Fausto Sánchez-Muñoz
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

5.  Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.

Authors:  Giuseppe Musumeci; Paola Castrogiovanni; Ignazio Barbagallo; Daniele Tibullo; Cristina Sanfilippo; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Piero Pavone; Rosario Caltabiano; Roberto Di Marco; Rosa Imbesi; Michelino Di Rosa
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.